In Fig. 3B, the BDNF gene expression in the AD group decreased compared to the sham group (P < 0.05), and the dose of 25 mg/kg of the effective substance increased its level to that of the sham group (P < 0.01). This evidence concerns the gene BDNF and Alzheimer disease.